Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
09 2019
Historique:
received: 23 07 2018
accepted: 08 03 2019
pubmed: 17 3 2019
medline: 24 3 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

We identified patients without medical record evidence of up-to-date colorectal cancer (CRC) screening and sent an invitation letter to self-schedule a colonoscopy without requiring prior primary care or gastroenterologist consultation. The aim of the study was to evaluate the response rate to the letter and factors associated with colonoscopy completion. A computer algorithm invited patients not up to date with CRC screening, with an INR < 1.5, and living within 300 miles of the Cleveland Clinic main campus through a letter. Patients scheduled a colonoscopy through a dedicated phone line without any prior physician consultation. Clinical, demographic, and socioeconomic variables were extracted from the EMR through natural language algorithms. We analyzed the percentage of patients who completed a colonoscopy within 6 months of sending the letter and factors associated with colonoscopy completion. A total of 145,717 letters were sent. 1451 patients were deceased and excluded from analysis. 3.8% (5442) of letter recipients completed a colonoscopy. The strongest factors associated with colonoscopy completion on multivariate analysis included family history of polyps (OR 3.1, 95% CI 2.3, 4.2) or CRC (OR 2.1, 95% CI 1.7, 2.5). Other factors included younger age, male gender, married status, closer distance to endoscopy center, number of visits in the year prior, statin use, and diabetes. There were no immediate procedural complications. Patient-initiated colonoscopy in response to letter invitation for CRC screening is effective and safe with safeguards established a priori. Consultation with a gastroenterologist or primary care physician is not necessary prior to colonoscopy. To our knowledge, this is the first study to evaluate patient-initiated colonoscopy for CRC cancer screening.

Sections du résumé

BACKGROUND AND AIM
We identified patients without medical record evidence of up-to-date colorectal cancer (CRC) screening and sent an invitation letter to self-schedule a colonoscopy without requiring prior primary care or gastroenterologist consultation. The aim of the study was to evaluate the response rate to the letter and factors associated with colonoscopy completion.
METHODS
A computer algorithm invited patients not up to date with CRC screening, with an INR < 1.5, and living within 300 miles of the Cleveland Clinic main campus through a letter. Patients scheduled a colonoscopy through a dedicated phone line without any prior physician consultation. Clinical, demographic, and socioeconomic variables were extracted from the EMR through natural language algorithms. We analyzed the percentage of patients who completed a colonoscopy within 6 months of sending the letter and factors associated with colonoscopy completion.
RESULTS
A total of 145,717 letters were sent. 1451 patients were deceased and excluded from analysis. 3.8% (5442) of letter recipients completed a colonoscopy. The strongest factors associated with colonoscopy completion on multivariate analysis included family history of polyps (OR 3.1, 95% CI 2.3, 4.2) or CRC (OR 2.1, 95% CI 1.7, 2.5). Other factors included younger age, male gender, married status, closer distance to endoscopy center, number of visits in the year prior, statin use, and diabetes. There were no immediate procedural complications.
CONCLUSIONS
Patient-initiated colonoscopy in response to letter invitation for CRC screening is effective and safe with safeguards established a priori. Consultation with a gastroenterologist or primary care physician is not necessary prior to colonoscopy. To our knowledge, this is the first study to evaluate patient-initiated colonoscopy for CRC cancer screening.

Identifiants

pubmed: 30877609
doi: 10.1007/s10620-019-05584-9
pii: 10.1007/s10620-019-05584-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2497-2504

Références

Gastrointest Endosc. 2006 Oct;64(4):556-62
pubmed: 16996349
CA Cancer J Clin. 2007 Nov-Dec;57(6):354-66
pubmed: 17989130
Prev Med. 2010 Jan-Feb;50(1-2):3-10
pubmed: 20006644
Ann Intern Med. 2010 May 18;152(10):668-76
pubmed: 20388703
Arch Intern Med. 2012 Apr 9;172(7):575-82
pubmed: 22493463
Public Health Rep. 2012 May-Jun;127(3):330-9
pubmed: 22547865
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):109-17
pubmed: 23118143
J Clin Oncol. 2013 Jun 1;31(16):1928-30
pubmed: 23589553
Cancer. 2013 Aug 1;119 Suppl 15:2940-6
pubmed: 23868488
Cancer. 2014 May 1;120(9):1290-314
pubmed: 24343171
Am J Gastroenterol. 2015 Jan;110(1):72-90
pubmed: 25448873
Cancer. 2015 Jul 1;121(13):2281-5
pubmed: 25763558
Gastrointest Endosc. 2015;81(6):1326-9
pubmed: 25865387
CA Cancer J Clin. 2015 Nov-Dec;65(6):497-510
pubmed: 26331705
JAMA. 2016 Feb 2;315(5):514-5
pubmed: 26836736
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
JAMA. 1982 May 14;247(18):2543-6
pubmed: 7069920

Auteurs

Gautam Mankaney (G)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA. mankang@ccf.org.

Maged Rizk (M)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Shashank Sarvepalli (S)

Department of Medicine, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Jeannie Bongorno (J)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Ari Garber (A)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Rocio Lopez (R)

Department of Biostatistics, and Quantitative Health Sciences, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

John McMichael (J)

Department of General Surgery, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Carol A Burke (CA)

Department of Gastroenterology and Hepatology, Digestive Disease and Surgical Institute, The Cleveland Clinic, 9500 Euclid Avenue/A30, Cleveland, OH, 44195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH